PRTA
PRTA
NASDAQ · Biotechnology

Prothena Corp Plc

Small-Cap Stocks Biotech Stocks Healthcare Stocks
$10.73
+0.21 (+2.00%)
As of May 10, 10:21 PM ET ·
Analyst Consensus
Buy
12
Analysts
Moderate
Coverage
Buy 8 67%
Hold 3 25%
Sell 1 8%
Price Target
Analyst Price Target +26.0% upside
Low Target $9.22
Average Target $13.52
High Target $14.31
Current Price $10.73
Current
$10.73
Target
$13.52
$9.22 $13.52 avg $14.31
Scenario Analysis
Bear Case
$9.22
-14.1%
Low target
Base Case
$13.52
+26.0%
Avg target
Bull Case
$14.31
+33.4%
High target
Risk/Reward
2.4x
Favorable
Price in Context
52-Week High
$11.69
-8.2% from high
52-Week Low
$4.32
+148.4% from low
Target vs 52W High
$13.52
+15.7% vs high
Next Earnings Report
May 13, 2026
1d
tomorrow
EPS Est: $-0.36
Earnings in 1 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 75% $257.58 +27.8%
AMGN
Amgen Inc
 Hold 44 48% $190.87 -42.5%
GILD
Gilead Sciences Inc
 Strong Buy 39 79% $362.68 +176.2%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 +2.0%
REGN
Regeneron Pharmaceuticals
 Strong Buy 38 79% $76.80 -89.3%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 75% $102.31 -65.3%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -19.5%
INSM
Insmed Inc
 Strong Buy 28 96% $143.40 +41.5%